DISCOUNT ZERTIFIKAT - KENVUE Stock

Certificat

DE000MG4LXA8

Market Closed - Börse Stuttgart 14:46:51 2024-06-28 EDT
15.98 EUR -1.48% Intraday chart for DISCOUNT ZERTIFIKAT - KENVUE
Current month-1.96%
1 month-3.09%
Date Price Change
24-06-28 15.98 -1.48%
24-06-27 16.22 -0.67%
24-06-26 16.33 0.00%
24-06-25 16.33 -0.91%
24-06-24 16.48 +0.61%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 02:46 pm

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying KENVUE INC.
Issuer Morgan Stanley
WKN MG4LXA
ISINDE000MG4LXA8
Date issued 2024-05-22
Cap 21 $
Last trading day 2025-03-21
Maturity 2025-03-21 (266 Days)
Parity 1 : 1
Emission price 16.93
Emission volume N/A
Payment day 2025-03-28
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 5.388 %
Sideways yield 5.728 %
Sideways yield pa 7.860 %
Outperformance point 22.2 $
Break even 17.20 €
Highest since issue 16.8
Lowest since issue 15.67
Spread 0.01
Spread %0.06%
Distance Cap -2.82 $
Distance Cap %-15.51%
Max. earning 3.553
Max. earning % 22.13 %

Company Profile

Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. The business is organized around 3 product families: - health products: for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - body care products: hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.); - other: notably oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.). Product marketing is assured through direct sales, distributors and the Internet.
Sector
-
More about the company

Ratings for Kenvue Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Kenvue Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
18.18 USD
Average target price
22.54 USD
Spread / Average Target
+23.97%
Consensus